Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ma. Laura Guzman"'
Autor:
Ma. Florencia Peralta, Ma. Laura Guzman, Ma. Estefanía Bracamonte, J. Diego Marco, Ma. Eugenia Olivera, Dolores C. Carrer, Paola A. Barroso
Publikováno v:
Heliyon, Vol 7, Iss 5, Pp e07136- (2021)
An efficacious topical treatment for cutaneous leishmaniasis (CL) is highly desirable but still an ongoing challenge. Systemic risedronate (Ris) has been reported to have anti-leishmanial properties and Eudragit EPO (EuE) has shown in vitro activity
Externí odkaz:
https://doaj.org/article/18057b7718e84694a725466e5b5db715
Autor:
Dolores C. Carrer, Ma. Laura Guzman, Ma. Eugenia Olivera, Ma. Florencia Peralta, J. Diego Marco, Paola Andrea Barroso, Ma. Estefanía Bracamonte
Publikováno v:
Heliyon
Heliyon, Vol 7, Iss 5, Pp e07136-(2021)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Heliyon, Vol 7, Iss 5, Pp e07136-(2021)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
An efficacious topical treatment for cutaneous leishmaniasis (CL) is highly desirable but still an ongoing challenge. Systemic risedronate (Ris) has been reported to have anti-leishmanial properties and Eudragit EPO (EuE) has shown in vitro activity
Autor:
Dolores C. Carrer, J. Diego Marco, Nadina A Usseglio, Ma. Eugenia Olivera, Ma. Estefanía Bracamonte, Ma. Laura Guzman, Ma Florencia Peralta, Paola Andrea Barroso
Publikováno v:
Drug delivery and translational research. 12(1)
Cutaneous leishmaniasis (CL) is a neglected tropical disease endemic in ~ 90 countries, with an increasing incidence. Presently available pharmacotherapy implies the systemic administration of moderately/very toxic drugs. Miltefosine (Milt) is the on
Autor:
L. C. Luciani Giacobbe, María Florencia Sanchez, Alvaro F. Jimenez-Kairuz, Carolina Beatriz Romañuk, L. P. Alarcón-Ramirez, Ma. Laura Guzman, F.D. Battistini, Fabiana L. Alovero, Ruben H. Manzo, María Eugenia Olivera
Publikováno v:
Drug Delivery and Translational Research. 8:123-131
This paper builds on a previous paper in which new ciprofloxacin extended-release tablets were developed based on a ciprofloxacin-based swellable drug polyelectrolyte matrix (SDPM-CIP). The matrix contains a molecular dispersion of ciprofloxacin ioni